EYEPOINT PHARMACEUTICALS, INC Profit Margin 2006-2021 | EYPT
Current and historical gross margin, operating margin and net profit margin for EYEPOINT PHARMACEUTICALS, INC (EYPT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. EYEPOINT PHARMACEUTICALS, INC net profit margin as of June 30, 2021 is -106.12%.
|EYEPOINT PHARMACEUTICALS, INC Annual Profit Margins
|EYEPOINT PHARMACEUTICALS, INC Quarterly Profit Margins
||Medical - Biomedical and Genetics
EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA.